PFE - Pfizer Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Cash flows from operating activities
Net Income
16,273,000
11,153,000
21,308,000
7,215,000
Depreciation & amortization
-
6,384,000
6,269,000
5,757,000
Deferred income taxes
-
-2,205,000
-2,410,000
-700,000
Stock based compensation
-
949,000
840,000
691,000
Change in working capital
-
-926,000
1,296,000
85,000
Accounts receivable
-
-644,000
259,000
-134,000
Inventory
-
-717,000
-357,000
365,000
Accounts Payable
-
431,000
46,000
871,000
Other working capital
-
13,631,000
14,253,000
13,902,000
Other non-cash items
-
-1,865,000
-10,608,000
209,000
Net cash provided by operating activites
-
15,827,000
16,470,000
15,901,000
Cash flows from investing activities
Investments in property, plant and equipment
-
-2,196,000
-2,217,000
-1,999,000
Acquisitions, net
-
0
-1,000,000
-18,368,000
Purchases of investments
-
-13,474,000
-18,133,000
-28,186,000
Sales/Maturities of investments
-
19,908,000
15,959,000
40,690,000
Other investing activites
-
287,000
650,000
52,000
Net cash used for investing activites
-
4,525,000
-4,741,000
-7,811,000
Cash flows from financing activities
Debt repayment
-
-9,620,000
-14,743,000
-15,875,000
Common stock issued
-
-
-
-
Common stock repurchased
-
-12,198,000
-5,000,000
-5,000,000
Dividends Paid
-
-7,978,000
-7,659,000
-7,317,000
Other financing activites
-
-589,000
-233,000
-196,000
Net cash used privided by (used for) financing activities
-
-20,440,000
-13,035,000
-8,921,000
Net change in cash
-
-205,000
-1,254,000
-1,046,000
Cash at beginning of period
-
1,431,000
2,595,000
3,641,000
Cash at end of period
-
1,225,000
1,342,000
2,595,000
Free Cash Flow
Operating Cash Flow
-
15,827,000
16,470,000
15,901,000
Capital Expenditure
-
-2,196,000
-2,217,000
-1,999,000
Free Cash Flow
-
13,631,000
14,253,000
13,902,000